% | $
Quotes you view appear here for quick access.


billyteex1 28 posts  |  Last Activity: Jun 27, 2016 7:31 AM Member since: Jul 17, 2006
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    Sell this co. by EOY!

    by f_schwark Jun 25, 2016 7:23 AM
    billyteex1 billyteex1 Jun 27, 2016 7:31 AM Flag

    Always dreaming rory. That RS years ago took the wind out of this and the RO were wasted money. Averaging down on this dog cost you clowns. I just knew I would be vindicated and leave you idiots talking to yourselves. How much they lose this quarter and I expect they will do another RS and start all over. How much is mechen now down? BTW fred, oos, tel, civil and most of the id's here are the same clown.

  • Reply to

    The real story on our HDF ?

    by parmentiersteve Jun 24, 2016 3:44 PM
    billyteex1 billyteex1 Jun 27, 2016 7:25 AM Flag

    Still talking to yourselves? I still get a laugh at how fast Oss took down his racial rant. How telcomist gave accounting advice to investors without a clue. If anyone had listen to him, they would be pulling their hair out, sitting on a loss that they cannot take. Hope rory gets his money back some day.

    Great investing rory. You are the man always holding a bag of krap.

  • billyteex1 by billyteex1 Jun 1, 2016 9:26 AM Flag

    Claimed he owned 200K shares between the share price of .42 and .47. If I am incorrect he can easily show us the trades. Like his actual bill for a fake trip to Tahiti. Now what is arlo valuation after not listening to my advice.....200K /40= 5K shares x 3.72= $18,600 = the 100K shares of mining he claimed he sold at .10 and his value is $28,600. Now what did he begin with 200K x .42 average= $84K. So by him not cleaning out his ears and instead using the k9uwa id, this cost him $55,400.

    The 515M shares I warned about cost him large. The biotech clowns lack the attention to details. Today arlo needs $11 move to breakeven. Pretty difficult to get that kind of move with a biotech without revenues. Frost saw the $20M low hanging fruit and sold his followers out. The insiders of Scavf received 515M shares, today still valued at $48M, the biotech clowns who paid double for their shares, now see a company go from $112M on paper to now $22M.

    Maybe arlo was too busy inventing new id's to understand that adding 515M shares wasn't going to immediate value this company at $355M. The value he needed to support his buys in the $18's. Today arlo has to invent imaginary flight connections, failing to include the airport code. I sometimes forget that arlo is 70 years old, with the intellect of a 8 year.

  • billyteex1 by billyteex1 May 24, 2016 10:04 AM Flag

    3.16M deferred revenues

    Svac had $10M cash at the end of the 1Q. They also have on the books deferred revenues of 3.16M, with 1.57M listed as short term and 1.63M listed as long term. They believe that the $10M in cash will last them 12 months?????

    I think hidden in these reports is that they have a strong contract to manufacture compounds for 10 different ph1 trials by other companies. They also have a deal with OPK to manufacture something on a billing basis. They do not mention the Dnase enzymes stuff at all.

    As investors we have to understand where the funding will come from. Can LVP get legs, can they manufacture drugs on scale and profit from it. What exact did Frost see here? Missing from the Web page now is anything about Svac second drug. The GVHD? Curious minds want to know where did that go off too?

    They also put out a SEC filing that they will use their web page instead of PR's to announce things. They suggest you get the VBIV alerts, so you are updated as fast as possible. Is this a cost saving move?

    With a stock that is already down 75% from the highs, I think we as investors need a little bone thrown our way. The insiders handed themselves 515M shares and 650M divided by 40.

    I don't expect an intelligent discussion, since most of the biotech investors here, can't tie their own shoes. We found that out at $18.80 when they just had blinders on. What could have been a very intelligent discussion, turned into a cluster F, with K(UWA and arlo, cdavis, Dk1949. Shame these clowns were this stupid. But then again they just like to sniff the hinney of Frost, with no brains to back their heads out of the crack.

    I sense a surprise is coming. Things always take more time then we wish with a biotech. The unsophisticated think just the opposite. Well let's let arlo place his thumbs. I don't mind reproducing this 20 times. It's not like we will get anything intelligent from that side anyways.

  • billyteex1 billyteex1 May 19, 2016 4:16 PM Flag

    Arlo let's see 10 thumbs down here also. Maybe you can get federal aid being this dumb.

  • Reply to


    by billyteex2 May 19, 2016 2:25 PM
    billyteex1 billyteex1 May 19, 2016 4:15 PM Flag


    Looks like I don't need a new game, you seem to rile old arlo, better then I can. 10 thumbs because you showed up. Please chime in more, getting arlo to change his id that many times......PRICELESS.

  • Reply to


    by billyteex1 May 19, 2016 11:22 AM
    billyteex1 billyteex1 May 19, 2016 11:23 AM Flag

    Chase that wind mill arlo.

  • billyteex1 by billyteex1 May 19, 2016 11:22 AM Flag

    svacfakeid39s57 • 38 minutes ago

    users liked this posts
    users disliked this posts


    They are suppose to have the CMV trial started in the next 6 weeks. Still nothing up on the Clinical trial site. The $25M they needed to raise was canceled, so I expect some news on funding. Could they just license the vac-b to GSK for a nice large check?

    There is a new update presentation on VBI site. It includes both companies and their outline going forward. I figure they need about $100M to advance the CMV, GBM, Vac-b, RSV and maybe a year away from seeing the cold storage benefits. They also state they are close to a third collaboration on the thermo stability.

  • Another wind mill for you arlo.

  • Reply to

    Arlo thinks he's Don Quixote

    by billyteex1 May 18, 2016 12:12 PM
    billyteex1 billyteex1 May 18, 2016 12:14 PM Flag

    Can he remember which id posted where? The counts are not even arlo and this is not fun unless you even this out and change those id's. You can be the poster child for stupid.

  • Chasing another wind mill.

  • Only a wind mill arlo.

  • Selling them for a another loss?

  • Reply to

    GBM competition

    by svacfakeid39s57 May 13, 2016 9:48 AM
    billyteex1 billyteex1 May 18, 2016 9:46 AM Flag

    Arlo try this one also. You can place thumbs all over the place. You are just a clown that over paid by a factor of 4 for svacf shares. Even though I tried to talk you off the ledge.

  • Reply to

    Finally some great discussions

    by limesaltshot May 16, 2016 10:25 AM
    billyteex1 billyteex1 May 17, 2016 5:11 PM Flag

    Deb here is a link to why the CT was granted to July 25, 2018.

    The trial for PVSRIPO data:

    Estimated Enrollment: 65
    Study Start Date: January 2012
    Estimated Study Completion Date: January 2018

    So there could be why we got CT treatment on a license deal. Of course this is speculation, but since both Duke and VBIV are involved with a investigating our GBM, there could be something there. Frost once called this merger a game changer.

    Hope we don't have to wait till 2018 for some news. The move today, maybe be some news on the way. Joint partnership and some cash would be very welcome right now. If the biotech clowns can get back to even, I will be up $100K.

  • Reply to

    Here is another article on the 60 minutes

    by billyteex1 May 16, 2016 11:30 AM
    billyteex1 billyteex1 May 16, 2016 11:36 AM Flag

    Then immediate a company with a drug VAL-083 jumps on the band wagon. I figure they want to catch a piece of the hype. You have to read everything you can find and I want arlo to satisfy his stupidity by place thumbs everywhere. As some of you are now getting. He is a perpetual loser every board he goes on. As rory, as edbi, as spanspur. The same thing always comes with it. He tries so hard and he always looks like a idiot.

    I can do this all day and if he's dumb enough to work this hard, I egg him on.

  • They think 60 minutes may have advanced something before it really is proven. Here is the article:

    A glioblastoma therapy touted in a "60 Minutes" report that aired Sunday evening, focusing on the use of the polio virus to treat glioblastoma, isn’t a particularly new idea and results are still unpublished -- but some oncologists are worried that patients might not have gotten that message from the program.

    The segment highlighted an approach being tested by researchers at Duke University involving an engineered poliovirus that is aimed at inducing an immune attack on glioblastoma tumor cells.

    Neuro-oncologist and team member Henry Friedman, MD, reported an increase in median survival of over 6 months. "So we've got patients that are out as far as 33, 34 months," he told 60 Minutes. "That is just unheard of in this disease."

    Study leader and director of Preston Robert Tisch Brain Tumor Center Darell Bigner, MD, PhD, did not call the patients "cured." But he reported that four patients are "in remission" (defined as living longer than 6 months).

    On the other hand, half of the 22 patients in the Duke trial have died.

    Since the story aired, patients have been calling Duke from all over the country, officials at Duke told MedPage Today. The Brain Tumor Center has received hundreds of calls and more than 200 online inquiries.

  • Reply to

    Posted a while back

    by aezstreet May 14, 2016 9:16 AM
    billyteex1 billyteex1 May 16, 2016 10:04 AM Flag

    In 35 minutes arlo changed his id 6 times. He is such a loser. He got busted on svacf board, actually replying to himself. Thanks for the compliment. I just watch the video by 60 minutes. I agree long shot that vbiv is the company they licensed it with. However, their are two CT filings that allow the company to keep certain news confidential.

    This may fall under that treatment, because with the results that Duke is having, if leaked could steal the value they expect down the road, by being bought out. For some reason we have stirred up arlo's immaturity of using his thumbs and he's like a mad dog right now. He wants so badly to have a voice in here and he knows that he offers nothing.

    Paying $18.80 a share when you were warned, is eating at him. He should actually be happy that there's a glimmer of hope for his bad investing. Look at the two CT filing on VBIV and see what you think.

  • billyteex1 billyteex1 Apr 26, 2016 6:34 AM Flag

    I'm sure they saw your photo of the sex change and they are thumbing downing how you look as a women. Don't be such a drama queen. BTW watch the IQD, it may change your tune here. Now shave your legs and act like a lady.

    Knowing you need $153 a share on VAPR to breakeven, you should worry about yourself.